Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Web – sheet or filament bases; compositions of bandages; or...
Reexamination Certificate
2007-04-10
2007-04-10
Richter, Johann (Department: 1616)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Web, sheet or filament bases; compositions of bandages; or...
C424S725000, C514S002600, C514S169000, C514S887000
Reexamination Certificate
active
10789836
ABSTRACT:
The present invention relates to the discovery of a transdermal delivery system that can deliver high molecular weight pharmaceuticals and cosmetic agents to skin cells. A novel transdermal delivery system with therapeutic and cosmetic application and methods of use of the foregoing is disclosed.
REFERENCES:
patent: 5318960 (1994-06-01), Toppo
patent: 5431924 (1995-07-01), Ghosh et al.
patent: 5472713 (1995-12-01), Fein et al.
patent: 5571671 (1996-11-01), Potter
patent: 5614212 (1997-03-01), D'Angelo et al.
patent: 5665378 (1997-09-01), Davis et al.
patent: 5708038 (1998-01-01), Davis
patent: 5716625 (1998-02-01), Hahn et al.
patent: 5744368 (1998-04-01), Goldbager et al.
patent: 5837853 (1998-11-01), Takashima et al.
patent: 5840746 (1998-11-01), Ducharme et al.
patent: 5849334 (1998-12-01), Rivlin
patent: 5861268 (1999-01-01), Tang et al.
patent: 5885597 (1999-03-01), Botknecht et al.
patent: 5891651 (1999-04-01), Roche et al.
patent: 5891857 (1999-04-01), Holt et al.
patent: 5958384 (1999-09-01), Holick
patent: 6103246 (2000-08-01), Tisdale et al.
patent: 6444234 (2002-09-01), Kirby et al.
patent: 6759056 (2004-07-01), Jordan
patent: 6787152 (2004-09-01), Kirby et al.
patent: 6946144 (2005-09-01), Jordan
patent: 2003/0104040 (2003-06-01), Kirby et al.
patent: 2005/0019384 (2005-01-01), Jordan
patent: 92/08470 (1992-05-01), None
patent: 97/09992 (1997-03-01), None
patent: 98/03163 (1998-01-01), None
patent: 98/33474 (1998-08-01), None
patent: 98/34629 (1998-08-01), None
Merck & Co., Inc., The Merck index, 1996, 12th edition, p. 1681.
Aloe Laboratories, Manufacturing Procedures, Product: Regular Traditional Hand Fillet Aloe Vera Juice, 1 page, date unknown.
Amadio et al., Nonsteroidal anti-inflammatory drugs, Postgraduate Medicine, 93(4):73-97 (1993).
Barel and Clarys, Study of the Stratum corneum Barrier Function by Transepidermal Water Loss Measurements: Comparison between Two Commercial Instruments, Skin Pharmacol., 8:186-195 (1995).
Biomedical Information Services, Ltd., Inspection Criteria, General Standard for Testing Purity of Aloe Vera, 7 pages, Copyright 1996.
Bronaugh and Collier, In vitro Percutaneous absorption studies: Principle, Fundementals, and Applications, eds., Bronaugh and Maibach, Boca Raton, Fl., CRC Presss, pp. 237-241 (1991).
Chattem Inc., Packaging—Flexall QuickGel, Copyright 1999.
Cohen et al., in Wound Healing/Biochemical and Clinical Aspects, 1sted. WB Saunders, Philadelphia (1992).
Collier et al., Maintenancea of Skin Viability during in Vitro Percuteneous Absorption/Metabolism Studies, Toxicoloy and Applied Pharmacology, 99:522-533 (1989).
Downing et al., Dermatology in General Medicine, Fitzpatrick, et al., eds., pp. 210-221 (1993).
Grindlay and Reynolds, The Aloe Vera Phenomenon: A Review of the Properties and Modern Uses of the Leaf Parenchyma Gel, J. of Ethnopharmacology, 16:117-151 (1986).
Hart et al., “Two Functionally and Chemically Distinct Immunomodulatory Compounds in the Gel of Aloe Vera,” J. of Ethnopharmacology, 23:61-71 (1988).
Hirata eta l., “biologically Active Constitutents of Leaves and Roots of the Aloe Vera Arborescens var. natalensis,” Z. Naturforsch, 32c:731-734 (1977).
http://www.natplus.com/products/productNumber=7124.
http://www.botanical.com/botanical/mgmh/f/franki3l.html.
Informational Packet, Sederma, Melaslow™, pp. 1-28, Dec. 2000.
Informational Packet, Sederma, Ichtyocollagene, pp. 1-19, Aug. 1993.
Informational Packet, Sederma, Etioline, pp. 1-14, Oct. 1996.
Informational Packet, Sederma, Matrixyl, pp. 1-44, Sep. 1999.
Informational Packet, “Guide to Specialty Ingredients for the Personal Care Industry,” CRODA, 15thAnniversary Issue, pp. 1-42, 2000.
International Aloe Science Council, Inc., The Datasheet—100% Pure Aloe Vera, 1 page, date unknown.
Nelson et al., “MidInfrared Lasor Ablation of Stratum Corneum Enhances in Vitro Percutaneous Transport of Drugs,” The Society for Investigative Dermatology, Inc., pp. 874-879 (1991).
O'Malley et al., “Emu Products, Increasing Production and Profitability,” Rural Industries Research & Development Corporation, pp. i-110 (Dec. 1999).
Pamphlet—The mighty macadamia,SPC ASIA, Mar. 2000.
Pamphlet—Certificate of Analysis for Florasolvs® PEG-16 Macadamia, Jun. 2001.
Pamphlet—Life Extension™, Apr. 2002.
Pamphlet—In a Nutshell,Reprinted from SPC, May 1999.
Pamphlet—A natural alternative,Reprinted from SPC Asia, May 1999.
Pamphlet—Melaslow™, date unknown.
Pamphlet—Patent N FR 00.11002 Melaslow™, date unknown.
Product Specification for FLORAESTERS® 20, Mar. 1997.
Product Specification for FLORAESTERS® 30, Mar. 1997.
Product Specification for FLORAESTERS® 60, Mar. 1998.
Product Specification for FLORAESTERS® 70, Jun. 1997.
Product Specification for FLORASOLVS® PEG-10 Sunflower, Jun. 1999.
Product Specification for FLORASUN® 90, Refined, Bleached, Winterized, Deodorized, Jan. 2000.
Product Specification for FLORAESTERS® IPJ, Feb. 2000.
Product Specification for FLORAESTERS® HIPJ, Oct. 1999.
Product Specification for FLORABEADS®, Jojoba 40/60, Sep. 1999.
Product Specification for FLORABEADS®, Jojoba White 60/100, Mar. 1998.
Product Specification for FLORASOLVS® PEG-80 Jojoba, Jun. 1999.
Product Specification for FLORASOLVS® PEG-120 Jojoba, Oct. 1999.
Product Specification for FLORAESTERS®, Jojoba Oil, Pasteurized, Not Refined, Jan. 2000.
Product Specification for FLORAESTERS® 15, Dec. 1998.
Product Specification for FLORABEADS®, Jojoba 28/60, Sep. 1999.
Ponec, M., “Epidermal lipids in vivo,” The Keratinocyte Handbook, Leigh et al., eds, pp. 351-363 (1994).
Taguchi et al., “Enhancement of Propylene Glycol Distribution in the Skin by High Purity cis-Unsaturated Fatty Acids with Different Alkyl Chain Lengths Having Different Double Bond Position,” Biol. Pharm. Bull., 22(4):407-411 (1999).
Woodin, L., “Cutting Postop pain,” RN, pp. 26-33 (1993).
http://www.essentialoils.co.za/macadamia—oil.htm, Macadamia oil for massage therapy and to help moisturize the skin, 2001.
George Konata M.
Knobbe Martens Olson & Bear LLP
Richter Johann
LandOfFree
Mixture for transdermal delivery of low and high molecular... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Mixture for transdermal delivery of low and high molecular..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mixture for transdermal delivery of low and high molecular... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3724907